Invesco Ltd. Reata Pharmaceuticals Inc Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$79.22 - $105.37 $4.98 Million - $6.63 Million
-62,902 Reduced 15.59%
340,654 $34.7 Million
Q1 2023

May 12, 2023
BUY
$30.85 - $93.17 $9.67 Million - $29.2 Million
313,452 Added 347.88%
403,556 $36.7 Million
Q4 2022

Feb 13, 2023
BUY
$22.15 - $42.11 $1.4 Million - $2.65 Million
62,997 Added 232.4%
90,104 $3.42 Million
Q3 2022

Nov 14, 2022
BUY
$19.41 - $36.49 $6,405 - $12,041
330 Added 1.23%
27,107 $681,000
Q2 2022

Aug 15, 2022
SELL
$20.71 - $36.5 $607,527 - $1.07 Million
-29,335 Reduced 52.28%
26,777 $814,000
Q1 2022

May 16, 2022
SELL
$24.12 - $39.6 $53.7 Million - $88.1 Million
-2,224,297 Reduced 97.54%
56,112 $1.84 Million
Q4 2021

Feb 14, 2022
SELL
$25.61 - $110.96 $29.7 Million - $129 Million
-1,158,395 Reduced 33.69%
2,280,409 $60.1 Million
Q3 2021

Nov 15, 2021
BUY
$100.0 - $143.02 $62.9 Million - $90 Million
629,088 Added 22.39%
3,438,804 $346 Million
Q2 2021

Aug 17, 2021
BUY
$78.27 - $151.29 $59 Million - $114 Million
753,356 Added 36.64%
2,809,716 $398 Million
Q1 2021

May 17, 2021
BUY
$94.25 - $132.81 $26.1 Million - $36.8 Million
276,885 Added 15.56%
2,056,360 $205 Million
Q4 2020

Feb 16, 2021
BUY
$102.03 - $184.62 $124 Million - $225 Million
1,216,844 Added 216.28%
1,779,475 $220 Million
Q3 2020

Nov 16, 2020
BUY
$93.53 - $163.34 $47.6 Million - $83.2 Million
509,453 Added 958.01%
562,631 $54.8 Million
Q2 2020

Aug 14, 2020
BUY
$126.3 - $176.56 $6.51 Million - $9.11 Million
51,583 Added 3234.04%
53,178 $8.3 Million
Q1 2020

May 15, 2020
SELL
$124.16 - $247.74 $6.25 Million - $12.5 Million
-50,342 Reduced 96.93%
1,595 $231,000
Q4 2019

Feb 14, 2020
BUY
$74.57 - $217.92 $3.87 Million - $11.3 Million
51,937 New
51,937 $10.6 Million
Q3 2019

Nov 14, 2019
SELL
$71.26 - $95.75 $1.34 Million - $1.8 Million
-18,750 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$77.72 - $94.35 $14,922 - $18,115
192 Added 1.03%
18,750 $1.77 Million
Q1 2019

May 15, 2019
BUY
$51.9 - $101.79 $740,924 - $1.45 Million
14,276 Added 333.4%
18,558 $1.59 Million
Q4 2018

Feb 14, 2019
BUY
$48.76 - $76.44 $208,790 - $327,316
4,282 New
4,282 $240,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email